Today's Low
₹ 1,202.35
Today's High
₹ 1,245.00
52 Weeks Low
₹ 686.80
52 Weeks High
₹ 1,034.30
Lower
₹ 1,084.80
Upper
₹ 1,325.80
Ipca Laboratories Limited manufactures and markets pharmaceutical formulations and active pharmaceutical ingredients (APIs) for various therapeutic segments in India. The company offers APIs in therapeutic areas of anti-hypertensive, anti-malarial, diuretic, DMARD, and anthelmintic. It also provides generic and branded formulations in the therapeutic segments, including cardiology, gastroenterology, dermatology, rheumatology, urology, ophthalmology, infectious disease, immunosuppressant, probiotics, respiratory, allergy, nutraceuticals, anti-neoplastic, malarial, neurology, psychiatry, orthopedics, helminthics, fever, hematology, hepatoprotective, diabetology, anti-epileptic, emollients/protectives, NSAIDs, rheumatology, anti-arthritic, and neuropathic pain, as well as products in various dosage forms comprising oral solids, powders for suspension, and liquid and dry injections. The company exports its products to approximately 100 countries worldwide. Ipca Laboratories Limited was incorporated in 1949 and is based in Mumbai, India.
No Data Found
No of shares Outstanding
EPS-TTM
Face Value
Book Value
Net Asset Value
ROE
ROA
ROCE
Dividend Yield
Total Debt
Sales Growth
PAT Growth
Particulars | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 | FY 2011 | FY 2010 | FY 2009 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Total Current Assets | 5,189.3 | 4,457.2 | 3,437.0 | 2,855.7 | 2,377.8 | 1,945.5 | 1,741.8 | 1,621.9 | 1,614.0 | 1,601.4 | 1,397.2 | 1,210.0 | 1,036.8 | 905.1 | 830.8 |
Total Non-Current Assets | 3,433.6 | 3,164.3 | 2,629.5 | 2,402.1 | 2,171.1 | 2,170.1 | 2,217.7 | 2,269.8 | 2,198.4 | 1,609.1 | 1,299.8 | 1,117.3 | 875.0 | 708.5 | 632.3 |
Total Assets | 8,622.9 | 7,621.5 | 6,066.4 | 5,257.8 | 4,548.8 | 4,115.6 | 3,959.5 | 3,891.7 | 3,812.4 | 3,210.6 | 2,697.0 | 2,327.3 | 1,911.8 | 1,613.6 | 1,463.1 |
Total Current Liabilities | 1,805.8 | 1,465.9 | 1,160.5 | 1,326.4 | 1,097.5 | 1,007.6 | 955.9 | 970.0 | 904.4 | 791.5 | 633.7 | 640.2 | 578.5 | 215.5 | 307.7 |
Total Non-Current Liabilities | 901.7 | 613.9 | 189.7 | 290.3 | 313.4 | 419.4 | 548.3 | 662.6 | 699.6 | 459.5 | 509.5 | 433.2 | 282.4 | 533.8 | 524.5 |
Shareholder's Funds | 5,842.0 | 5,464.8 | 4,701.7 | 3,627.5 | 3,122.4 | 2,688.6 | 2,455.3 | 2,259.2 | 2,208.4 | 1,959.7 | 1,553.8 | 1,254.0 | 1,051.6 | 864.9 | 631.3 |
Total Liabilities | 8,622.9 | 7,621.5 | 6,066.4 | 5,257.8 | 4,548.8 | 4,115.6 | 3,959.5 | 3,891.7 | 3,812.4 | 3,210.6 | 2,697.0 | 2,327.3 | 1,911.8 | 1,613.6 | 1,463.1 |
The Industry Quick Ratio stands at 1.60, vs the Quick Ratio of 1.16, which results in a Negative aspect.
The Industry Current Ratio stands at 2.30, vs the Current Ratio of 2.15, which results in a Negative aspect.
The Industry Debt to Equity Ratio stands at 0.22, vs the Debt to Equity Ratio of 0.13, which results in a Positive aspect.
The Industry Price to BV stands at 6.12, vs the Price to BV of 4.77, which results in a Negative aspect.
Particulars | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 | FY 2011 | FY 2010 | FY 2009 | FY 2008 | FY 2007 | FY 2006 | FY 2005 | FY 2004 | FY 2003 | FY 2002 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Total Income | 6,204.3 | 5,796.7 | 5,394.9 | 4,619.0 | 3,745.7 | 3,257.8 | 3,156.2 | 2,867.1 | 3,144.4 | 3,281.8 | 2,805.9 | 2,356.0 | 1,897.9 | 1,595.2 | 1,314.9 | 1,110.4 | 960.9 | 778.2 | 703.7 | 639.9 | 501.6 | 429.4 |
Total Expenditure | 5,301.0 | 4,539.1 | 3,913.7 | 3,728.6 | 3,067.4 | 2,815.8 | 2,740.8 | 2,593.4 | 2,630.3 | 2,569.8 | 2,268.3 | 1,928.5 | 1,558.1 | 1,293.2 | 1,151.3 | 919.7 | 774.3 | 677.0 | 595.2 | 527.2 | 403.8 | 361.5 |
Operating Profit(Excl OI) | 1,055.0 | 1,379.3 | 1,610.4 | 977.0 | 752.9 | 500.1 | 470.2 | 314.5 | 572.8 | 764.0 | 577.5 | 475.8 | 428.8 | 345.9 | 195.7 | 231.7 | 208.5 | 115.3 | 125.6 | 128.6 | 99.9 | 69.3 |
Add: Other Income | 151.8 | 121.7 | 129.2 | 86.5 | 74.7 | 58.1 | 54.8 | 40.8 | 58.7 | 52.0 | 39.9 | 48.3 | 89.0 | 43.9 | 32.1 | 41.0 | 21.9 | 14.2 | 17.1 | 15.8 | 2.1 | 1.4 |
Operating Profit | 1,055.0 | 1,379.3 | 1,610.4 | 977.0 | 752.9 | 500.1 | 470.2 | 314.5 | 572.8 | 764.0 | 577.5 | 475.8 | 428.8 | 345.9 | 195.7 | 231.7 | 208.5 | 115.3 | 125.6 | 128.6 | 99.9 | 69.3 |
Less: Interest | 48.2 | 11.2 | 12.3 | 19.8 | 22.2 | 27.6 | 26.9 | 34.6 | 32.1 | 30.2 | 36.5 | 44.4 | 32.4 | 32.9 | 37.8 | 24.0 | 24.7 | 16.0 | 12.3 | 7.4 | 7.2 | 15.7 |
PBDT | 1,006.9 | 1,368.1 | 1,598.2 | 957.2 | 730.7 | 472.5 | 443.3 | 279.9 | 540.6 | 733.7 | 541.0 | 431.4 | 396.5 | 313.0 | 158.0 | 207.8 | 183.8 | 99.4 | 113.3 | 121.1 | 92.8 | 53.5 |
Less: Depreciation Amortization | 261.6 | 232.4 | 209.2 | 210.5 | 182.4 | 177.7 | 173.0 | 163.3 | 179.6 | 103.1 | 86.7 | 67.1 | 55.8 | 46.7 | 39.7 | 32.5 | 29.5 | 24.9 | 19.2 | 17.3 | 12.7 | 11.0 |
PBT & Exceptional Items | 745.3 | 1,135.7 | 1,389.0 | 746.7 | 548.3 | 294.8 | 270.3 | 116.6 | 361.1 | 630.6 | 454.3 | 364.3 | 340.7 | 266.3 | 118.3 | 175.3 | 154.3 | 74.5 | 94.1 | 103.8 | 80.1 | 42.6 |
Less: Exceptional Income Expenses | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.8 | 0.0 | 0.0 | 0.0 | 0.0 | -3.0 |
Profit Before Tax | 745.3 | 1,135.7 | 1,389.0 | 738.9 | 546.5 | 290.5 | 262.1 | 116.6 | 361.1 | 630.6 | 454.3 | 364.3 | 340.7 | 266.3 | 118.3 | 175.3 | 155.2 | 74.5 | 94.1 | 103.8 | 80.1 | 39.5 |
Less: Taxation | 253.4 | 224.8 | 240.1 | 135.3 | 104.2 | 51.1 | 67.5 | 20.4 | 101.9 | 152.4 | 129.9 | 88.1 | 78.4 | 62.7 | 23.3 | 35.8 | 29.4 | 14.5 | 23.8 | 30.1 | 17.8 | 7.9 |
Profit After Tax | 491.9 | 911.0 | 1,148.8 | 603.6 | 442.2 | 239.4 | 194.5 | 96.2 | 259.2 | 478.2 | 324.3 | 276.2 | 262.3 | 203.5 | 95.1 | 139.5 | 125.8 | 60.0 | 70.3 | 73.7 | 62.3 | 31.6 |
Earnings Per Share | 18.6 | 34.9 | 44.9 | 24.0 | 17.6 | 9.5 | 7.7 | 3.7 | 10.1 | 19.0 | 12.8 | 11.0 | 10.5 | 8.2 | 4.0 | 5.4 | 5.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
The Industry Dividend Yield stands at 0.59, vs the Dividend Yield of 0.33, which results in a Negative aspect.
The Industry PAT Growth stands at 32.49, vs the PAT Growth of 36.48, which results in a Positive aspect.
The Industry PAT Margin stands at 9.68, vs the PAT Margin of 12.98, which results in a Positive aspect.
The Industry PE Ratio stands at 42.11, vs the PE Ratio of 53.87, which results in a Positive aspect.
Particulars | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 | FY 2011 | FY 2010 | FY 2009 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Profit Before Tax | 745.3 | 1,135.7 | 1,389.0 | 738.9 | 546.5 | 290.5 | 262.1 | 116.6 | 361.1 | 630.6 | 454.3 | 364.3 | 340.7 | 266.3 | 118.3 |
Tax Paid | -223.7 | -202.0 | -245.6 | -152.2 | -110.8 | -57.5 | -51.3 | -29.4 | -75.0 | -130.5 | -91.6 | -80.1 | -64.4 | -45.9 | -22.4 |
Adjustment | 235.2 | 195.1 | 183.1 | 247.4 | 187.4 | 192.5 | 174.9 | 211.1 | 188.6 | 139.9 | 126.2 | 157.0 | 39.1 | 70.5 | 147.3 |
Changes In Working Capital | 745.3 | 1,135.7 | 1,389.0 | 738.9 | 546.5 | 290.5 | 262.1 | 116.6 | 361.1 | 630.6 | 454.3 | 364.3 | 340.7 | 266.3 | 118.3 |
Cash Flow after changes in Working Capital | 1,029.5 | 1,058.1 | 1,335.7 | 722.6 | 611.9 | 398.6 | 333.2 | 738.1 | 543.2 | 652.8 | 480.3 | 433.9 | 278.6 | 238.3 | 176.0 |
Cash Flow from Operating Activities | 805.8 | 856.1 | 1,090.1 | 570.4 | 501.0 | 341.1 | 281.9 | 708.7 | 468.2 | 522.3 | 388.8 | 353.8 | 214.2 | 191.5 | 152.4 |
Cash Flow from Investing Activities | -725.0 | -855.1 | -520.7 | -509.7 | -165.1 | -135.4 | -148.8 | -218.3 | -689.3 | -369.0 | -259.9 | -285.9 | -198.1 | -117.4 | -108.7 |
Cash Flow from Financing Activities | 507.2 | 426.8 | -305.8 | -136.5 | -183.2 | -130.4 | -159.1 | -461.5 | 250.5 | -136.1 | -82.9 | -71.8 | -17.8 | -74.0 | -42.4 |
Net Cash Inflow / Outflow | 588.1 | 427.8 | 263.6 | -75.8 | 152.8 | 75.3 | -26.0 | 28.8 | 29.4 | 17.2 | 46.0 | -3.9 | -1.7 | 0.1 | 1.3 |
Opening Cash & Cash Equivalents | 990.9 | 559.0 | 295.4 | 370.9 | 218.2 | 142.8 | 168.9 | 140.1 | 74.3 | 56.7 | 10.7 | 9.1 | 10.8 | 10.7 | 9.4 |
Closing Cash & Cash Equivalent | 1,579.0 | 990.9 | 559.0 | 295.4 | 370.9 | 218.2 | 142.8 | 168.9 | 103.7 | 74.3 | 56.7 | 10.7 | 9.1 | 10.8 | 10.7 |
The Industry PFCF Ratio stands at 25.03, vs the PFCF Ratio of 35.93, which results in a Positive aspect.
The Industry PCF RATIO stands at 24.36, vs the PCF RATIO of 15.38, which results in a Negative aspect.
Particulars | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | Dec 2020 | Sep 2020 | Jun 2020 | Mar 2020 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Sales | 20,528.6 | 20,339.6 | 15,875.8 | 15,116.3 | 15,460.0 | 16,009.5 | 15,857.4 | 12,891.0 | 14,304.7 | 15,444.3 | 15,657.9 | 11,146.6 | 14,098.3 | 13,611.0 | 15,344.0 | 10,737.6 |
Total Income | 20,753.1 | 20,725.1 | 16,324.3 | 15,480.2 | 15,768.9 | 16,371.8 | 16,078.5 | 13,036.4 | 14,434.0 | 15,625.1 | 15,868.1 | 11,345.8 | 14,252.1 | 13,765.5 | 15,464.9 | 10,874.9 |
Total Expenditure | 17,215.3 | 17,126.9 | 12,799.6 | 13,305.9 | 13,301.4 | 13,403.1 | 13,165.1 | 10,697.7 | 11,226.6 | 11,788.5 | 11,492.5 | 8,857.5 | 10,429.0 | 10,009.1 | 9,460.8 | 9,052.8 |
PBIDT (Excl OI) | 3,313.3 | 3,212.7 | 3,076.2 | 1,810.4 | 2,158.6 | 2,606.4 | 2,692.3 | 2,193.3 | 3,078.1 | 3,655.8 | 4,165.4 | 2,289.1 | 3,669.3 | 3,601.9 | 5,883.2 | 1,684.8 |
Other Income | 224.5 | 385.5 | 448.5 | 363.9 | 308.9 | 362.3 | 221.1 | 145.4 | 129.3 | 180.8 | 210.2 | 199.2 | 153.8 | 154.5 | 120.9 | 137.3 |
Operating Profit | 3,537.8 | 3,598.2 | 3,524.7 | 2,174.3 | 2,467.5 | 2,968.7 | 2,913.4 | 2,338.7 | 3,207.4 | 3,836.6 | 4,375.6 | 2,488.3 | 3,823.1 | 3,756.4 | 6,004.1 | 1,822.1 |
Interest | 334.0 | 441.2 | 313.8 | 184.5 | 108.4 | 93.1 | 69.4 | 33.8 | 14.3 | 10.6 | 18.2 | 17.0 | 22.9 | 23.1 | 27.4 | 36.7 |
Exceptional Items | 680.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
PBDT | 3,883.9 | 3,157.0 | 3,210.9 | 1,989.8 | 2,359.1 | 2,875.6 | 2,844.0 | 2,304.9 | 3,193.1 | 3,826.0 | 4,357.4 | 2,471.3 | 3,800.2 | 3,733.3 | 5,976.7 | 1,785.4 |
Depreciation | 995.0 | 903.4 | 692.7 | 695.4 | 665.7 | 637.4 | 617.1 | 609.4 | 586.5 | 569.6 | 558.7 | 525.0 | 535.2 | 521.2 | 510.3 | 639.4 |
Profit Before Tax | 2,888.9 | 2,253.6 | 2,518.2 | 1,294.4 | 1,693.4 | 2,238.2 | 2,226.9 | 1,695.5 | 2,606.6 | 3,256.4 | 3,798.7 | 1,946.3 | 3,265.0 | 3,212.1 | 5,466.4 | 1,146.0 |
Tax | 662.4 | 879.2 | 856.1 | 483.7 | 537.3 | 770.0 | 742.6 | 287.6 | 573.3 | 679.1 | 707.7 | 309.3 | 567.3 | 525.9 | 998.9 | 292.0 |
Provisions and contingencies | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Profit After Tax | 2,226.5 | 1,374.4 | 1,662.1 | 810.7 | 1,156.1 | 1,468.2 | 1,484.3 | 1,407.9 | 2,033.3 | 2,577.3 | 3,091.0 | 1,637.0 | 2,697.7 | 2,686.2 | 4,467.5 | 854.0 |
Net Profit | 2,226.5 | 1,374.4 | 1,662.1 | 810.7 | 1,156.1 | 1,468.2 | 1,484.3 | 1,407.9 | 2,033.3 | 2,577.3 | 3,091.0 | 1,637.0 | 2,697.7 | 2,686.2 | 4,467.5 | 854.0 |
ADDITIONAL INFOS: | ||||||||||||||||
Equity Capital | 253.7 | 253.7 | 253.7 | 253.7 | 253.7 | 253.7 | 253.7 | 253.7 | 253.7 | 253.7 | 253.7 | 253.7 | 253.7 | 253.7 | 252.7 | 252.7 |
Reserves | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
EPS | 7.1 | 5.7 | 6.4 | 3.0 | 4.3 | 5.7 | 5.6 | 5.1 | 7.8 | 19.7 | 24.2 | 12.7 | 21.1 | 21.1 | 35.3 | 6.6 |
Operating Profit Margin | 17.2 | 17.7 | 22.2 | 14.4 | 16.0 | 18.5 | 18.4 | 18.1 | 22.4 | 24.8 | 27.9 | 22.3 | 27.1 | 27.6 | 39.1 | 17.0 |
Net Profit Margin | 10.8 | 6.8 | 10.5 | 5.4 | 7.5 | 9.2 | 9.4 | 10.9 | 14.2 | 16.7 | 19.7 | 14.7 | 19.1 | 19.7 | 29.1 | 8.0 |
The Industry Net Sales Growth stands at 11.00, vs the Net Sales Growth of 23.32, which results in a Positive aspect.
The Industry Mcap Growth stands at 19.42, vs the Mcap Growth of 41.27, which results in a Positive aspect.
Type | Classic | Woodie | Camarilla |
---|---|---|---|
R4 | 1,322.70 | 1,358.49 | 1,260.86 |
R3 | 1,296.80 | 1,301.38 | 1,249.13 |
R2 | 1,270.90 | 1,273.19 | 1,245.22 |
R1 | 1,254.15 | 1,258.73 | 1,241.31 |
Pivot | 1,228.25 | 1,230.54 | 1,228.25 |
S1 | 1,211.50 | 1,216.08 | 1,233.49 |
S2 | 1,185.60 | 1,187.89 | 1,229.58 |
S3 | 1,168.85 | 1,173.43 | 1,225.67 |
S4 | 1,152.10 | 1,102.59 | 1,213.94 |
(All Values are in INR)
1 Day
1 Week
1 Month
Stoch RSI
100.00
Bearish
RSI
62.49
Neutral
ROC
3.70
Bullish
UltimateOscillator
61.60
Neutral
Williams Indicator
-6.56
Bearish
CCI Indicator
103.26
Neutral
MACD
-2,069.73
Bearish
Stochastic Indicator
88.86
Neutral
ATR
36.75
Low Volatility
Ex-Date | Ratio | Record Date |
---|
Ex-Date | Ratio | Record Date |
---|---|---|
Announcement Date | Dividend Amount | Dividend Percentage of FV | Dividend Type |
---|---|---|---|
22-11-2023 | 2.00 | 200 | Interim |
22-11-2022 | 4.00 | 400 | Interim |
22-11-2021 | 8.00 | 400 | Interim |
Date Of Conduct | Board Meeting Details |
---|---|
14-02-2024 | Quarterly Results |
10-11-2023 | Quarterly Results & Interim Dividend |
10-08-2023 | Quarterly Results |
29-05-2023 | Audited Results |
14-02-2023 | Quarterly Results |
11-11-2022 | Quarterly Results & Interim Dividend |
10-08-2022 | Quarterly Results |
24-05-2022 | Audited Results & Amalgamation |
14-02-2022 | Quarterly Results |
13-11-2021 | Interim Dividend & Stock Split & Quarterly Results |
05-08-2021 | Quarterly Results |
28-05-2021 | Audited Results |